Literature DB >> 14667552

Nonpharmacological prevention of osteoporotic fractures.

Xavier Deprez1, Patrice Fardellone.   

Abstract

In postmenopausal women, the nonpharmacological prevention of osteoporotic fractures pursues the dual objective of minimizing bone loss and preventing falls. In women with a low fracture risk, optimizing the dietary intake of calcium is the main nutritional goal. Regular sustained physical activity should be encouraged. In older women, the high risk of proximal femoral fractures warrants a number of preventive measures, including calcium and vitamin D supplementation, correction of protein deficiency if needed, and minimization of the risk of falls. Hip protectors may be useful in institutionalized women at high risk for falls. These nonpharmacological measures should be part of a comprehensive customized management program used to complement standard pharmacological therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667552     DOI: 10.1016/j.jbspin.2003.09.004

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  6 in total

Review 1.  Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  Steven Boonen; Jean-Jacques Body; Yves Boutsen; Jean-Pierre Devogelaer; Stefan Goemaere; Jean-Marc Kaufman; Serge Rozenberg; Jean-Yves Reginster
Journal:  Osteoporos Int       Date:  2005-01-26       Impact factor: 4.507

2.  Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club.

Authors:  J-J Body; P Bergmann; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-05-18       Impact factor: 4.507

3.  Decreased bone mineral density in adult familial Mediterranean fever patients: a pilot study.

Authors:  Elif Suyani; Mehmet Akif Ozturk; Serpil Muge Deger; Mehmet D Demirag; Berna Goker; Seminur Haznedaroglu
Journal:  Clin Rheumatol       Date:  2008-06-14       Impact factor: 2.980

Review 4.  Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club.

Authors:  J-J Body; P Bergmann; S Boonen; Y Boutsen; O Bruyere; J-P Devogelaer; S Goemaere; N Hollevoet; J-M Kaufman; K Milisen; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2011-03-01       Impact factor: 4.507

5.  2015 Guidelines for Osteoporosis in Saudi Arabia: Recommendations from the Saudi Osteoporosis Society.

Authors:  Yousef Al-Saleh; Riad Sulimani; Shaun Sabico; Hussein Raef; Mona Fouda; Fahad Alshahrani; Mohammad Al Shaker; Basma Al Wahabi; Mir Sadat-Ali; Hanan Al Rayes; Salwa Al Aidarous; Siham Saleh; Fakhr Al Ayoubi; Nasser M Al-Daghri
Journal:  Ann Saudi Med       Date:  2015 Jan-Feb       Impact factor: 1.526

6.  Rhizoma drynariae total flavonoids combined with calcium carbonate ameliorates bone loss in experimentally induced Osteoporosis in rats via the regulation of Wnt3a/β-catenin pathway.

Authors:  Yimei Hu; Panyun Mu; Xu Ma; Jingru Shi; Zhendong Zhong; Lingyuan Huang
Journal:  J Orthop Surg Res       Date:  2021-12-04       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.